Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q3 2015 13F Holders as of 30 Sep 2015
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 7,110,273
- Share change
- -112,062
- Total reported value
- $20,112,000
- Price per share
- $2.84
- Number of holders
- 11
- Value change
- -$538,914
- Number of buys
- 4
- Number of sells
- 5
Report period
Q3 2015
Institutions
11
Top holders
10
AUPH full security history
Newer quarter: Q4 2015
Previous quarter: Q2 2015
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$7,691,000 | — | 30 Jun 2015 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.5%
|
1,941,144
|
$5,812,000 | — | 30 Jun 2015 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.86%
|
1,142,676
|
$3,451,000 | — | 30 Jun 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.54%
|
711,499
|
$2,130,000 | — | 30 Jun 2015 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.39%
|
524,751
|
$1,585,000 | — | 30 Jun 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
145,200
|
$439,000 | — | 30 Jun 2015 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.08%
|
104,003
|
$314,000 | — | 30 Jun 2015 | |
| Cheyne Capital Management (UK) LLP |
13F
|
Company |
0.07%
|
90,000
|
$274,000 | — | 30 Jun 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
10,919
|
$33,000 | — | 30 Jun 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,700
|
$14,000 | — | 30 Jun 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Jun 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
400
|
$1,000 | — | 30 Jun 2015 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Jun 2015 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2015
As of 30 Sep 2015,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,110,273 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, Longwood Capital Partners LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, Cheyne Capital Management (UK) LLP, ROYAL BANK OF CANADA, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2015 vs Q2 2015 Across Filers
Q2 2015 holders
13
Q3 2015 holders
11
Holder diff
-2
| Investor | Q2 2015 Shares | Q3 2015 Shares | Share Diff | Share Chg % | Q2 2015 Value $ | Q3 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.